Considerations for Biopharmaceuticals and Implications for Biosimilars
Fill in the form on the right handside to download this presentation
This presenation explores:
• Complexity of Biologics
• FDA Draft Guidance on Biosimilars
• Comparability – What does that mean?
• Examples and Analytical Methods Used to monitor PTM’s
• Emerging Technologies